Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: A single institutional study with almost uniform dose with different five treatment schedules

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

? 2016 Aoki et al.Background: To evaluate clinical outcomes of stereotactic body radiotherapy (SBRT) for localized primary and oligometastatic lung tumors by assessing efficacy and safety of 5 regimens of varying fraction size and number. Methods: One-hundred patients with primary lung cancer (n = 69) or oligometastatic lung tumors (n = 31), who underwent SBRT between May 2003 and August 2010, were included. The median age was 75 years (range, 45-88). Of them, 98 were judged to have medically inoperable disease, predominantly due to chronic illness or advanced age. SBRT was performed using 3 coplanar and 3 non-coplanar fixed beams with a standard linear accelerator. Fraction sizes were escalated by 1 Gy, and number of fractions given was decreased by 1 for every 20 included patients. Total target doses were between 50 and 56 Gy, administered as 5-9 fractions. The prescribed dose was defined at the isocenter, and median overall treatment duration was 10 days (range, 5-22). Results: The median follow-up was 51.1 months for survivors. The 3-year local recurrence rates for primary lung cancer and oligometastasis was 6 % and 3 %, respectively. The 3-year local recurrence rates for tumor sizes ?3 cm and >3 cm were 3 % and 14 %, respectively (p = 0.124). Additionally, other factors (fraction size, total target dose, and BED10) were not significant predictors of local control. Radiation pneumonia (? grade 2) was observed in 2 patients. Radiation-induced rib fractures were observed in 22 patients. Other late adverse events of greater than grade 2 were not observed. Conclusion: Within this dataset, we did not observe a dose response in BED10 values between 86.4 and 102.6 Gy. SBRT with doses between 50 and 56 Gy, administered over 5-9 fractions achieved acceptable tumor control without severe complications.

Cite

CITATION STYLE

APA

Aoki, M., Hatayama, Y., Kawaguchi, H., Hirose, K., Sato, M., Akimoto, H., … Takai, Y. (2016). Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: A single institutional study with almost uniform dose with different five treatment schedules. Radiation Oncology, 11(1). https://doi.org/10.1186/s13014-016-0581-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free